Astal Laboratories
MACROINTERNATIONALEXPORTLTD NSE
Astal Laboratories
Commercial ServicesNSE: MACROINTERNATIONALEXPORTLTD BSE: ASTALLTD Trading & Distributors
Key Fundamentals
MicrocapTrading & DistributorsCommercial ServicesMarket Cap
₹329 Cr
Volatility
Moderate
P/E Ratio
22.6
EBITDA
₹12.78 Cr
Return on Equity
24.8%
Debt to Equity
0.15
Book Value
₹77.65
EPS
₹2.81
52W High
₹103.2
52W Low
₹60.45
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.96 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 4.53%
- Company has high debtors of 229 days.
- Promoter holding has decreased over last 3 years: -56.6%
Growth Rate
Revenue Growth
142% higher than
3Y
Net Income Growth
-6.97% lower than
3Y
Cash Flow Change
-124% higher than
3Y
ROE
638% higher than
3Y
ROCE
646%
EBITDA Margin (Avg.)
-59.2% lower than
3Y
Quarterly Results
| Particulars | Mar 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Sales | 23.47 | 52.24 | 134 | 101 |
| Expenses | 19.29 | 48.69 | 124 | 88.69 |
| Operating Profit | 4.18 | 3.55 | 10.19 | 12.25 |
| OPM % | 17.81% | 6.8% | 7.6% | 12.14% |
| Other Income | 0.04 | 0.04 | 0.1 | 0.14 |
| Interest | 0.27 | 0.33 | 1.09 | 1.18 |
| Depreciation | 0.1 | 0.12 | 0.86 | 0.86 |
| PBT | 3.85 | 3.14 | 8.34 | 10.35 |
| Tax % | 28.57% | 24.52% | 7.91% | 8.99% |
| Net Profit | 2.74 | 2.36 | 7.68 | 9.42 |
| EPS in Rs | 2.79 | 2.19 | 1.82 | 2.15 |
Profit & Loss
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 64 | 249 |
| Expenses | 51 | 228 |
| Operating Profit | 13 | 21 |
| OPM % | 20% | 8% |
| Other Income | 0 | 0 |
| Interest | 1 | 2 |
| Depreciation | 0 | 1 |
| PBT | 12 | 18 |
| Tax % | 25% | 17% |
| Net Profit | 9 | 15 |
| EPS in Rs | 9.08 | 3.48 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 10 | 42 |
| Reserves | 26 | 292 |
| Borrowings | 13 | 50 |
| Other Liabilities | 14 | 135 |
| Total Liabilities | 63 | 518 |
| Fixed Assets | 11 | 268 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 52 | 251 |
| Total Assets | 63 | 518 |
Cash Flow
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | -13 | -18 |
| Investing | -8 | -2 |
| Financing | 3 | 3 |
| Net Cash Flow | -17 | -17 |
| Free Cash Flow | -18 | -19 |
| CFO/OP | -96 | -80 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 157 | 229 |
| Inventory Days | 112 | 113 |
| Days Payable | 82 | 206 |
| Cash Conversion Cycle | 187 | 135 |
| Working Capital Days | 97 | 114 |
| ROCE % | — | 9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Astal Laboratories insights
58 extracted metrics + investor summaries across FY10–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
11 Sep - ACESO Research Labs LLP disclosed promoter equity share purchase under SEBI PIT regulations. 11 Sep - ACESO Research Labs LLP disclosed promoter equity share purchase under SEBI PIT regulations.
2
Clarification sought from Astal Laboratories Ltd
11 May - Exchange has sought clarification from Astal Laboratories Ltd on May 11, 2026 with reference to significant movement in price, in order to ensure that investors … 11 May - Exchange has sought clarification from Astal Laboratories Ltd on May 11, 2026 with reference to significant movement in price, in order to ensure that investors …
3
Price Movement Clarification
5h - Company says recent share price movement is market-driven and no undisclosed material event exists. 5h - Company says recent share price movement is market-driven and no undisclosed material event exists.
4
Intimation Under Regulation 30 (LODR), 2015- Website
30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46. 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46.
5
Intimation Under Regulation 30 (LODR), 2015- Website
30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46. 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46.
4
Announcement Under Regulation 30 (LODR) - Letter Of Annual Report & AGM Notice Web Link. 7 Sept 2026
General_Announcements
Frequently Asked Questions about Astal Laboratories
What does Astal Laboratories Ltd do?
Astal Laboratories Ltd is engaged in Manufacturing and Trading of all kinds of active Pharmaceutical Ingredients (Bulk Drugs).[1]
Where is Astal Laboratories Ltd (512600) listed?
Astal Laboratories Ltd trades as MACROINTERNATIONALEXPORTLTD on the NSE and under code ASTALLTD on the BSE.
Which sector does Astal Laboratories Ltd belong to?
Astal Laboratories Ltd is classified under the Commercial Services sector, in the Trading & Distributors industry.
What is the market capitalisation of Astal Laboratories Ltd?
Astal Laboratories Ltd has a market capitalisation of ₹328.93 Cr, which places it in the Small Cap band.
What is the PE ratio of Astal Laboratories Ltd?
Astal Laboratories Ltd trades at a PE ratio of 22.60, on earnings per share of ₹2.81, against a book value of ₹77.65 per share.
What is the 52-week high and low of Astal Laboratories Ltd?
Over the last 52 weeks Astal Laboratories Ltd has traded between ₹60.45 and ₹103.2.
What is the Return on Equity (ROE) of Astal Laboratories Ltd?
Astal Laboratories Ltd reported a return on equity of 24.80%. Its debt-to-equity ratio is 0.15.
Company Information
Astal Laboratories Ltd is engaged in Manufacturing and Trading of all kinds of active Pharmaceutical Ingredients (Bulk Drugs).[1]
Website astallabs.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512600.md for Astal Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.